NP213 (Novexatin)

The first, rapid-acting solution for nail disorders which is based on the nail’s natural defence mechanisms

NP213 is a novel peptide, generated from NovaBiotics’ proprietary technology platform.

NP213 is based on the natural peptides present within nails and skin and which play a crucial role in maintaining healthy tissue.

Clinical & laboratory studies have demonstrated that Novexatin®, a brush-on (topical) formulation containing NP213 is safe, well-tolerated and effective in resolving nail disorders following just one month of once-daily application. Novexatin® works to rapidly restore nail health, improving condition and appearance (within days as reported by users in a clinical study) by hydrating the nail and mimicking the body’s peptide defence system.

Healthcare Burden and Global Market

Nail disorders are estimated to affect up to 12% of the world’s population and treatments for these conditions represent a growing global market estimated to reach $10 billion by 2032. There are a number of environmental and medical factors associated with nail disorders including physical insult to the nail, infection, increased age, poor circulation, compromised immunity and diabetes. Current treatments can require months of use with application required more than once a day, nail filing etc. They can include antifungals with well-described toxicity/adverse effects and other chemicals and preservatives. The market is poised for rapid uptake of a novel fast-acting treatment with the unique and highly differentiated features of Novexatin®.